Search

Browse Subject Areas

For Authors

Submit a Proposal

Biomanufacturing

Transforming Production of Biologics and Biopharmaceuticals


Edited by Sandip Kunar, Jagadeesha T, and D. Sathis Kumar
Series: Advances in Production Engineering
Copyright: 2026   |   Expected Pub Date:2026/06/30
ISBN: 9781394440511  |  Hardcover  |  
1016 pages

One Line Description
The book provides a comprehensive and forward-looking exploration of the
technologies, processes, and innovations that are reshaping the production
of biologics and biopharmaceuticals through advanced biomanufacturing.

Audience
This book is designed for professionals and researchers across both academia and industry involved in the development, manufacture and production of biologics and biopharmaceuticals.

Description
Biomanufacturing stands at the forefront of a new era in life sciences, reshaping the conception, development, and delivery of advanced biologics and biopharmaceuticals to address global health challenges. Biomanufacturing uses living systems, such as genetically modified cells and microorganisms, to create complex molecules. But these developments also bring about new challenges, such as maintaining strict adherence to Good Manufacturing Practices and ensuring the stability and consistency of biological products. These developments are speeding up production schedules, enhancing product quality, and reducing manufacturing costs. This book offers a comprehensive and forward-looking exploration of the rapidly evolving landscape of biologics production, bringing together contributions from leading experts in biotechnology, engineering, and regulatory science to examine the technologies, strategies, and systems revolutionizing how biologics are developed, scaled, and delivered to patients.
Covering topics such as continuous processing, single-use technologies, process automation, and quality-by-design (QbD), this book serves as both a practical guide and strategic roadmap. It addresses the full biomanufacturing lifecycle—from early-stage development to commercial-scale production—and tackles critical regulatory, scalability, and quality challenges. This essential guide equips you with the insight needed to navigate and lead in this transformative era of pharmaceutical innovation.
Readers will find the volume:
• Explores the latest technologies driving efficiency and innovation in biologics production, including continuous manufacturing and single-use systems;
• Features expert insights from industry leaders, researchers, and regulatory professionals shaping the future of biomanufacturing;
• Covers key regulatory, scalability, and quality challenges with real-world case studies and solutions;
• Bridges academic and industrial perspectives, making it a valuable resource for both newcomers and seasoned professionals.

Back to Top
Author / Editor Details
Sandip Kunar, PhD is an Associate Professor in the Department of Mechanical Engineering, Aditya University, Surampalem, Andhra Pradesh, India. He has published more than 60 research papers in various reputed international journals and conference proceedings, 60 book chapters, 20 books, and one patent. His research interests include non-conventional machining processes, micromachining processes, biomanufacturing, advanced manufacturing technology, and industrial engineering.

Jagadeesha T., PhD is an Associate Professor in the Mechanical Engineering Department, the National Institute of Technology Calicut, Kerala, India, with more than 25 years of experience. He has developed workbooks and has four patents and more than 75 publications in international journals and conferences. His research interests are advanced machining, additive manufacturing, fluid power control, advanced materials, and vibration and noise control.

D. Sathis Kumar, PhD is the Principal of Aditya Pharmacy College, Surampalem, Andhra Pradesh, India. He has published 54 research articles in esteemed national and international journals, presented papers at reputed conferences, and authored one book. His primary research areas include analytical method development, statistical optimization using software tools, green analytical chemistry, phytochemical analysis, and quality control studies.

Back to Top

Table of Contents
Preface
Acknowledgements
Part 1: Foundations of Biomanufacturing
1. Introduction to Biomanufacturing
Sandip Kunar, Jagadeesha T., Anusha Mylavarapu, Ajithkumar Sitharaj, Gurudas Mandal and Satishkumar P.
1.1 Introduction
1.2 Transformations in Biomanufacturing
1.3 Industrial Biotechnology and Biomanufacturing from a Historical Perspective
1.4 Fundamentals of Bioprocessing and Biomanufacturing
1.5 Innovations in Bioprocessing
1.6 Need to Shift to a Bio-Based Economy
1.7 Biological Systems as a Biofactory
1.7.1 Bacterial Biofactory
1.7.2 Yeast Biofactory
1.7.3 Insect Cell Biofactory
1.7.4 Mammalian Cell Culture
1.7.5 Biosensors
1.8 Progress in Biomanufacturing
1.9 Case Studies of Innovative Bioprocesses
1.10 Overview of Biomaterials
1.10.1 Biomaterials Classification
1.10.2 Features of Biomaterials
1.10.3 Applications of Biomaterials
1.11 Manufacturing Process for Porous Implants
1.11.1 Powder Metallurgy
1.11.2 Additive Manufacturing
1.11.3 Electrospinning
1.12 Investment and Strategic Alliances to Boost Commercial Biomanufacturing
1.12.1 Partnerships for Product Development
1.12.2 Expanding the Implementation of Novel Solutions
1.13 Challenges and Limitations in Bioprocessing and Biomanufacturing
1.14 Conclusion
1.15 Future Prospects in Biomanufacturing
References
2. Mathematical Modeling and Simulation Techniques for Biomanufacturing
Jagadeesha T. and Sandip Kunar
2.1 Introduction
2.2 Biomanufacturing Processes with Examples
2.2.1 Upstream Processing
2.2.2 Bio Reactor Operations
2.2.3 Downstream Processing
2.2.4 Cell and Tissue Based Biomanufacturing
2.2.5 Integration of Process and Control
2.2.6 Modular Biomanufacturing
2.3 Mathematical Modelling in Biomanufacturing
2.3.1 General Form of Bioprocess Models
2.3.2 Kinetic Models Used in Biomanufacturing
2.3.3 Transport Phenomena and PDE Models
2.3.4 Thermodynamic and Stoichiometric Models
2.4 Simulations in Biomanufacturing
2.4.1 Bio Reactor Simulations Using CFD (Computational Fluid Dynamics)
2.4.2 Multi-Scale Modeling and Simulation
2.4.3 Finite Element Modeling in Scaffold and Tissue Engineering
2.4.4 Dynamic Simulation of Bioprocess Kinetics
2.4.5 Digital Twins and Data-Driven Simulation Approaches
2.5 Conclusions and Future Opportunities in Biomanufacturing
References
3. Potential Material for Bio‑Printing Applications
Amey Dukle, Sirisha Puttabanthi and Mamilla Ravi Sankar
3.1 Introduction
3.2 Factors Affecting Bioink Functionality
3.2.1 Rheological Properties
3.2.2 Shelf Life and Stability
3.2.3 Transportability
3.2.4 Cost
3.3 Natural Polymers for Bioink Preparation
3.4 Synthetic Polymer for Bioink Preparation
3.5 Composite Materials for Bioink Preparation
3.6 Emerging Materials in Bioprinting
3.6.1 Stimuli-Responsive Smart Biomaterials
3.6.2 Biowaste Derived Sustainable Bioinks
3.7 Conclusions
References
4. 3D Bioprinting in Precision Biomanufacturing: From Design to Functional Tissue Constructs
Ajithkumar Sitharaj, Idhayaraja S., Arulmurugan B. and Sandip Kunar
4.1 Introduction
4.2 Core Technologies and Mechanisms of 3D Bioprinting
4.2.1 Critical Parameters Influencing Bioprinting Fidelity and Performance
4.3 Bioinks: The Core of Functional Bioprinting
4.3.1 Classification of Bioinks
4.4 Design and Modeling for Bioprinted Constructs
4.4.1 Finite Element Modeling and Mechanical Simulation
4.5 Bioprinting Functional Tissues and Constructs
4.6 Translating Bioprinting into Scalable Biomanufacturing
4.7 Future Directions and Emerging Trends
4.8 Conclusion
References
Part 2: Process Improvement and Lean Integration
5. Application of Lean Technologies in Biomanufacturing
Ranjita Swain, Rudra Narayan Mohapatro and Sunita Routray
5.1 Introduction to Lean in Biomanufacturing
5.2 Principles of Lean Manufacturing
5.3 Key Lean Tools and Their Applications in Biomanufacturing
5.3.1 Value Stream Mapping (VSM) in Biomanufacturing
5.3.1.1 Key Applications of VSM in Biomanufacturing
5.3.2 Cleanroom Organization in Biomanufacturing
5.3.2.1 Zoning & Layout Design
5.3.2.2 Material and Equipment Management
5.3.2.3 Environmental Monitoring
5.3.3 Kaizen in Biomanufacturing
5.3.4 Standard Work in Biomanufacturing
5.3.5 Just-In-Time (JIT) in Biomanufacturing
5.3.6 Kanban Systems
5.3.7 Root Cause Analysis (e.g., Fishbone, 5 Whys)
5.4 Digital Lean and Smart Biomanufacturing
5.4.1 Integration with Industry 4.0 Tools (IoT, AI, Digital Twins)
5.4.2 Lean Analytics Dashboards for Real-Time Monitoring
5.4.3 Automation to Support Lean Workflows
5.5 Challenges and Considerations in Lean Biomanufacturing
5.5.1 Regulatory Constraints (FDA & EMA)
5.5.2 Process Variability and Biological Unpredictability
5.5.3 Culture Change and Resistance among Scientific Staff Related to Lean Biomanufacturing
5.5.4 Need for Training and Multidisciplinary Collaboration Related to Lean Biomanufacturing
5.6 Case Studies
5.6.1 Case 1: Lean Implementation in a Monoclonal Antibody Production Plant
5.6.2 Case 2: Continuous Improvement in Vaccine Manufacturing
5.7 Conclusion and Future Perspectives
References
6. Issues and Problems for the Biopharmaceutical Industry
Sarthak Prasad Sahoo and Sonali Bhujabal
6.1 Overview of Biopharmaceutical Industry
6.2 History and Evolution of the Industry
6.3 Scope of the Chapter
6.4 Distinction from Traditional Small-Molecule Pharmaceuticals
6.5 Impact on Global Health and Economies
6.6 Research and Development (R&D) Challenges
6.6.1 High Cost and Risk of Development
6.6.2 Complexity of Biologic Molecules
6.6.3 Drug Discovery Pipeline Drought/Attrition
6.6.4 Intellectual Property (IP) Protection
6.6.5 Data Management and Analytics
6.7 Manufacturing and Supply Chain Hurdles
6.7.1 Complex Manufacturing Processes
6.7.2 Quality Control (QC) and Quality Assurance (QA)
6.7.3 Supply Chain and Scalability Challenges
6.7.4 Sustainability in Biomanufacturing
6.8 Regulatory and Compliance Burdens
6.9 Workforce, Market Access and Commercialization Challenges
6.10 Ethical, Societal, and Public Perception Concerns
6.11 Future Recommendations or Probable Solutions
6.12 Conclusion
References
7. Bio Manufacturing for Sustainable Production
Ashok Thulluru, Nawaz Mahammed, Reshma Tadipatri, Sundeep Kadasi, Gouri Sankar Kandukuri and Anusha Sanampudi
7.1 Introduction
7.1.1 Definition and Scope of Bio-Manufacturing
7.1.2 Historical Perspective and Evolution of Bio-Manufacturing
7.1.3 Importance of Bio-Manufacturing in Modern Pharmaceutical and Biologics Production
7.2 Sustainable Bio-Manufacturing (Principles and Frameworks)
7.2.1 Green Chemistry and Circular Bioeconomy
7.2.2 Regulatory Drivers and Global Sustainability Goals
7.2.3 Key Metrics for Evaluating Sustainability
7.3 Platforms and Technologies in Bio-Manufacturing
7.3.1 Cell Culture Systems (CHO, HEK293, Microbial, Yeast)
7.3.2 Single-Use Bioreactors and Modular Systems
7.3.3 Continuous Manufacturing and Process Intensification
7.4 Biologics and Biopharmaceuticals: Manufacturing Workflow
7.4.1 Upstream Processing: Cell Line Development and Optimization
7.4.2 Purification and Formulation
7.4.3 Quality by Design (QbD) and Process Analytical Technologies (PAT)
7.5 Innovations Transforming Bio-Manufacturing
7.5.1 Digital Twins and AI-Driven Process Control
7.5.2 3D Bio-Printing and Microfluidic Bio-Factories
7.5.3 Synthetic Biology and Gene Editing Tools
7.6 Case Studies in Sustainable Production
7.6.1 mRNA Vaccines and Rapid Pandemic Response
7.6.2 Biosimilars and Cost-Efficient Therapeutics
7.6.3 Plant-Based and Cell-Free Manufacturing Systems
7.7 Challenges and Regulatory Considerations
7.7.1 Scalability and Tech Transfer
7.7.2 Regulatory Compliance and Global Harmonization
7.7.3 Environmental and Bioethical Concerns in Biomanufacturing
7.8 Future Directions and Emerging Trends
7.8.1 Integration of Automation and Smart Manufacturing
7.8.2 Decentralized and On-Demand Production Models
7.8.3 Role of Bio-Manufacturing in Climate Resilience
7.9 Conclusion
7.9.1 Summary of Key Insights
7.9.2 Roadmap for Future Sustainable Bio-Manufacturing
References
8. Additive Manufacturing for Biomedical Applications: Concepts, Methods, and Future Trends
Idhayaraja S., Ajithkumar Sitharaj, Arulmurugan B. and Sandip Kunar
8.1 Introduction
8.2 Smart Design Strategies in Biomedical Additive Manufacturing
8.2.1 Topology Optimized Implants for Load-Adaptive Functionality
8.2.2 Generative Design Algorithms for Complex Biomedical Structures
8.3 Bio-Compatible and Functional Material Systems for AM
8.3.1 Biodegradable Polymeric Platforms for Temporary Therapeutic Support
8.3.2 AM-Processed Metallic Biomaterials for Structural and Osseointegrative Performance
8.3.3 Bioceramic and Hybrid Composites for Regenerative Scaffolding
8.4 4D Printing and Stimuli-Responsive Biomaterials in Medicine
8.4.1 Shape-Memory Polymers for Environmentally Activated Implants
8.5 Bioprinting and WAAM-Based Scaffold Fabrication for Regenerative Medicine
8.5.1 Bioink Formulation Strategies for Cell-Laden and Bioactive Constructs
8.6 Conclusion
References
9. Role of Functionally Graded Materials in Biomedical Applications
Debarupam Gogoi, Mihir Kumar Pandit and Arun Kumar Pradhan
9.1 Introduction
9.2 Fundamentals of Functionally Graded Materials
9.2.1 Definition and Historical Perspective
9.2.2 Types of Gradients
9.2.3 Analytical and Numerical Modeling
9.2.4 Manufacturing Routes for Biomedical FGMs
9.3 Biological Rationale for Graded Implants
9.4 Classification of Biomedical FGMs
9.4.1 Metal–Metal FGMs
9.4.2 Metal–Ceramic FGMs
9.4.3 Biodegradable Metal FGMs
9.4.4 Polymer–Ceramic FGMs
9.4.5 Hydrogel FGMs
9.4.6 Surface-Graded Coatings (FGCs)
9.5 Design Considerations
9.5.1 Mechanical Integrity
9.5.2 Porosity and Permeability
9.5.3 Corrosion and Degradation
9.5.4 Bio-Functionality
9.6 Manufacturing Techniques in Detail
9.6.1 Selective Laser Melting (SLM)
9.6.2 Direct Ink Writing (DIW)
9.6.3 Spark-Plasma Sintering (SPS) of Metal–Ceramic Bilayers
9.6.4 Surface Engineering Routes
9.6.5 Hybrid and Post-Processing
9.7 Orthopedic Applications
9.7.1 Joint Replacements
9.7.2 Bone Plates and Screws
9.7.3 Biodegradable Fixation Devices
9.7.4 Scaffolds for Bone Defects
9.8 Dental Applications
9.8.1 Mechanical Gradients (Modulus Gradients)
9.8.2 Chemical Gradients
9.8.3 Antibacterial Top Layers
9.8.4 Clinical and Experimental Validation
9.9 Cardiovascular and Soft-Tissue Devices
9.9.1 Cardiovascular Stents
9.9.2 Soft-Tissue Grafts
9.10 Drug-Delivery and Tissue-Engineering Scaffolds
9.10.1 Hydrogel Gradients
9.10.2 Layer-by-Layer Assembled Microspheres
9.11 Case Studies and Recent Advances (2024–2025)
9.11.1 Multifunctional CuO-Doped Ti–SiC–HA FGM Composite
9.11.2 Bibliometric Trends
9.11.3 Universal FGM Modeling Framework
9.12 Challenges and Future Prospects
9.12.1 Standardization
9.12.2 Long-Term Corrosion and Wear
9.12.3 Regulatory Pathways
9.12.4 Data-Driven Design
9.12.5 Clinical Translation
9.13 Conclusion
References
Part 3: Artificial Intelligence and Digital Transformation
10. Advances and Challenges in AI-Driven Sustainable and Green Bio-Manufacturing for Bio-Based Production
Sree Sowkhya Thaninki, Pushpalatha Kondamuri, Lakshmi Madhavi Chitra, Parinaya Sri Lotha and Shaik Rafi
10.1 Introduction
10.2 Developing Mammalian and Microbial Cell Platforms for Eco-Friendly Bio-Manufacturing
10.2.1 Design and Optimization of Microbial Cell Factories
10.2.1.1 Increasing Productivity through Metabolic Engineering
10.2.2 Mammalian Cell Factories: Precision and Complexity
10.2.2.1 Enhancing Productivity and Glycosylation
10.2.2.2 CRISPR for Mammalian Cell Line Engineering
10.3 AI Foundation: Tools & Techniques in Bio-Manufacturing
10.3.1 Data Acquisition, Management & Sensor Integration
10.3.1.1 Advanced Sensor Networks and Peak Time Monitoring
10.3.1.2 Multi-Modal Sensing and Image-Based Analytics
10.3.1.3 IoT Connectivity, Edge Computing and Data Management
10.3.2 Machine Learning, Deep Learning & Digital Twins
10.3.2.1 Machine Learning & Deep Learning
10.3.2.2 Digital Twins
10.3.3 Hybrid AI Approaches for Transparency Explain Ability
10.3.3.1 Blending Mechanistic Models with Data-Drive AI
10.3.3.2 Explainable (XAI Techniques)
10.4 AI-Applications in Bio-Process Development
10.4.1.1 AI-Accelerated Target Identification and Pathway Optimization
10.4.1.2 Optimization and AI-Guided CRISPR Design
10.4.2 Fermentation and Upstream Process Optimization
10.4.2.1 Predictive Modeling and Real Time Control
10.4.2.2 Robustness to Feedback Variability and Process Flexibility
10.4.3 Downstream Processing, Purification and Quality Control
10.4.3.1 Optimization of Purification Stages
10.4.3.2 Real Time Impurity Profiling and Quality Control (QC)
10.5 AI-Enhanced Green Bio-Manufacturing: A Comprehensive Overview
10.5.1 AI-Enabled Resource and Energy Efficiency
10.5.2 Resource Recovery and Circular Economy Ways
10.5.3 Biodegradable Materials and Bio-Fabrication
10.6 Compliance, Ethics and Governance
10.6.1 Data Integrity, Bias and Transparency
10.6.2 Frameworks for Regulation
10.6.3 Biological Safety, Biological Security and Management
10.7 Human-in-the-Loop System and SME Engagement
10.7.1 Institutional Capacity, Training and Talent Development
10.7.1.1 Ongoing Professional Growth
10.8 Scalability & Commercial Implementation
10.8.1 Transitioning from Laboratory to Industrial Scale-Modelling Complexities
10.8.2 Case Studies: Microbial Cell Factories & Precision Fermentation
10.9 Emerging Trends & Future Prospects
10.9.1 Synergistic CRISPR and AI for Next-Gen Bio-Engineering
10.9.2 Intelligent Bio Factories & Advanced Green Bio-Manufacturing
10.9.3 A Road-Map for an AI-Powered Bio-Economy That Resilient, Ethical and Sustainable
10.10 Challenges and Recommendations
10.10.1 Progress and Challenges in Brief
10.10.2 Recommendations for Industry, Academia and Policy Makers
10.10.3 Concluding Reflections on the AI-Driven Green Bio-Manufacturing Horizon
10.10.4 Conclusion
References
11. Microbial Biomanufacturing Using Agro-Industrial Wastes for Sustainable Production of Biologics and Biopharmaceuticals
Lakshmi Madhavi Chitra, K. Sujana, A. Harani, Pushpalatha Kondamuri, Sree Sowkhya Thaninki and Parinaya Sri Lotha
11.1 Introduction
11.2 Fundamentals of Microbial Bio-Manufacturing
11.2.1 Definition and Scope
11.2.2 Microorganisms Used in Bio Manufacturing
11.2.3 Advantages over Chemical Synthesis
11.3 Agro-Industrial Wastes as Fermentation Substrates
11.3.1 Classification and Composition
11.3.2 Pretreatment and Hydrolysis Techniques
11.3.3 Environmental and Economic Benefits
11.4 Fermentation Strategies for Waste Valorization
11.4.1 Submerged Fermentation
11.4.2 Solid State Fermentation
11.4.3 Mixed Culture Fermentation
11.4.4 Bioreactor Design and Process Scale-Up
11.5 Process Optimization and Lean Bio-Manufacturing
11.5.1 Optimization Techniques
11.5.2 Lean Bio-Manufacturing Principles
11.6 Metabolic Engineering and Synthetic Biology in Bio-Manufacturing
11.6.1 Core Approaches
11.6.2 Benefits of Waste-to-Value Bio-Manufacturing
11.7 Downstream Processing Biologics
11.7.1 Cell Separation and Clarification
11.7.2 Cell Disruption for Intracellular Products
11.7.3 Primary Recovery (or) Concentration
11.7.4 High–Resolution Purification
11.7.5 Polishing and Formulation
11.7.6 Challenges in Downstream Processing for By-Product
11.8 Case Studies
11.8.1 Bio-Ethanol Production from Lignocellulose Waste
11.8.2 Citric Acid Production from Fruit and Vegetable Processing Waste
11.8.3 Lactic Acid Production from Dairy and Starch Waste
11.8.4 Production of Microbial Enzymes from Agricultural Residues
11.8.5 Vitamin B12 Production from Agro-Industrial Wastes
11.9 Regulatory Framework and Quality Standards
11.9.1 Regulatory Bodies and Guidelines
11.9.2 Challenges Specific to Agro-Waste Feedstock
11.10 Future Perspectives and Research Opportunities
11.10.1 Advanced Technologies and Integration
11.10.2 Expanding the Scope of Waste Feedstocks and Products
11.10.3 Interdisciplinary Research and Policy Support
11.11 Conclusion
References
12. Smart Biomanufacturing: Integrating Lean Technologies and Digital Automation in Biologics Production
Thenmozhi Annadurai, Abishek Balasundaram, Bava Dhareni Pandia Rajan and Venkateshan Narayanan
12.1 Introduction
12.2 Lean Manufacturing in Biologics Production
12.2.1 Types of Wastes in Lean
12.2.1.1 Defects
12.2.1.2 Inventory
12.2.1.3 Overprocessing
12.2.1.4 Waiting Time
12.2.1.5 Transportation and Motion
12.2.1.6 Overproduction
12.2.1.7 Underutilized Talent
12.3 Implementation of Lean Tools in Bio-Pharmaceutical Industry
12.3.1 Limitation of Implementation of Lean in Bio-Pharmaceutical Industry
12.4 Digital Automation in Smart Biomanufacturing
12.4.1 Role of Digitalization in Smart Bio-Manufacturing 3
12.4.1.1 Productivity
12.4.1.2 Quality of Product
12.4.1.3 Quality Control
12.4.1.4 Efficiency
12.4.1.5 Flexibility
12.4.2 Key Technology for Digitalization in Bio-Manufacturing
12.4.2.1 Internet of Things [IoT]
12.4.2.2 Blockchain Technology
12.4.2.3 Artificial Intelligence (AI) and Machine Learning (ML)
12.4.2.4 Process Analytical Technology (PAT)
12.4.2.5 Advanced Automatization and Robotics
12.4.2.6 Digital Twin Technology
12.4.3 Automation in Upstream and Downstream Process in Biomanufacturing
12.5 Integration of Lean with Digitalization in Biomanufacturing
12.5.1 Synergistic Effect
12.5.2 Data Driven Process Control
12.5.3 Application of Data Driven in Biomanufacturing
12.5.3.1 Design of Protein
12.5.3.2 Cell Engineering
12.5.3.3 Prediction of Kinetic Parameters
12.6 Challenges and Future Perspectives
12.7 Conclusion
References
13. Additive Manufacturing for Biomedical Applications
Geetika Kumari Salwan and Sayon Dey
13.1 Introduction
13.2 Fundamentals of Additive Manufacturing
13.2.1 Definition and Principles
13.2.2 Classification of Additive Manufacturing Technologies
13.3 Materials Use in Biomedical AM
13.4 Applications of AM in Biomedical Engineering
13.5 Challenges and Limitations
13.6 Future Perspectives
13.7 Conclusions
References
14. Artificial-Intelligence-Based Lean Biomanufacturing: Analytical Measures to Eliminate Wastes and Maximize Process Efficiency
Rompicherla Srividya, K.S.N.V. Prasad, B. Karuna, Bijoy Kumar Purohit, Vijaya Kumar Talari, Appala Naidu Uttaravalli and A.V. Raghavendra Rao
14.1 Introduction to Lean Biomanufacturing and Industry 4.0
14.1.1 Overview of Lean Principles in Biomanufacturing
14.1.1.1 Benefits and Challenges in Biomanufacturing
14.1.2 The Impact of Industry 4.0 on Process Innovation
14.1.3 Drivers for Integrating AI into Lean Bioprocessing
14.2 AI Technologies Transforming Lean Bioprocesses
14.2.1 Machine Learning, Neural Networks, and Predictive Analytics
14.2.2 Digital Twins and Real-Time Process Simulation
14.2.3 Anomaly Detection and AI-Based Monitoring Systems
14.3 AI-Driven Optimization in Upstream and Downstream Operations
14.3.1 Raw Material Inventory Management
14.3.2 Process Parameter Optimization for Yield and Quality
14.3.3 Minimizing Energy Usage and Reducing Downtime
14.4 Data Integrity, Model Validation, and Regulatory Compliance
14.4.1 Data Quality and Traceability in GMP Environments
14.4.1.1 Data Governance and System Controls
14.4.2 AI Model Verification and Lifecycle Methods
14.4.2.1 Lifecycle Management
14.4.2.2 Documentation and Change Control
14.4.3 Navigating Regulatory Requirements for AI in Biomanufacturing
14.4.3.1 Key Regulatory Expectations
14.4.3.2 Addressing Regulatory Challenges
14.4.3.3 Preparing for Regulatory Inspections
14.5 Case Studies: AI-Enabled Lean Transformation in Biopharma
14.5.1 Practical Examples from Manufacturing Lines
14.5.2 Measurable Outcomes: Productivity, Efficiency, and Sustainability Gains
14.5.3 Lessons Learned and Best Practices
14.6 Roadmap for Implementing AI-Powered Lean Biomanufacturing
14.6.1 Strategic Measures to Adopting AI in Lean Initiatives
14.6.2 Overcoming Challenges and Barriers to Implementation
14.6.3 Future Perspectives: Scaling, Agility, and Continuous Improvement
14.7 Conclusion
14.7.1 Regulatory and GxP Considerations for AI-Enabled Operations
14.7.2 Economic and Scalability Considerations
14.7.3 Emerging Trends and Technologies
14.7.4 Future Directions
Abbreviations
References
Part 4: Emerging Biomaterials and Bio-Printing Innovations
15. Emerging Bio-Inks for 3D Bioprinting of Functional Tissues in Biomanufacturing Applications
B. Karuna, K.S.N.V. Prasad, Rompicherla Srividya, Navapet Vikas Reddy, Tirumala Shreya, Komere Vasu and A.V. Raghavendra Rao
15.1 Introduction to Bioprinting
15.1.1 Regenerative Medicine Landscape of 3D Bioprinting
15.1.2 Bio-Ink Significance in Biomanufacturing
15.1.2.1 Important Uses of Bio-Inks in Biomanufacturing
15.2 Fundamentals of Bio-Inks
15.2.1 Essential Elements of Bio-Inks
15.2.2 Definition and Fundamental Characteristics of Bio-Inks
15.2.3 Bio-Ink: Its-Practice within Tissue Engineering
15.3 Bio-Ink Classification
15.3.1 Natural Bio-Inks
15.3.1.1 Alginate-Based Systems
15.3.1.2 Collagen and Gelatin
15.3.1.3 Other Natural Polymers (e.g., Fibrin, Hyaluronic Acid)
15.3.2 Synthetic Bio-Inks
15.3.2.1 Polyethylene Glycol (PEG)
15.3.2.2 Other Synthetic Polymers Pluronic
15.3.3 Others (Hybrid and Composite Bio-Inks)
15.4 Important Properties of Bio-Inks
15.4.1 Rheological Characteristics
15.4.2 Printing and Structural Faithfulness
15.4.3 Compatibility and Cell Viability
15.5 Recent Developments in Bio-Ink Creation
15.5.1 Bio-Inks Stimuli Responsive (Smart)
15.5.2 Functionalized and Conductive Bio-Inks
15.5.3 Factor-Bioactive Systems
15.6 Crosslinking Strategy
15.6.1 Crosslinking in Physics
15.6.2 Crosslinking-Chemical
15.6.3 Photo Crosslinking and Enzymatic Methods
15.6.4 Influence While Causing Mechanical Instability and Tissue Maturation
15.7 Examples of Functional Tissue Fabrication
15.7.1 Liver Tissue Model
15.7.2 Cardiac Tissue Engineering
15.7.3 Constructs of Skin and Wound Heals
15.7.4 Usage Orthopedic and Cartilage
15.7.4.1 Tissue Cartilage Engineering
15.7.4.2 Orthopedic (Bone and Osteochondral) Uses
15.8 Industrial and Clinical Translation
15.8.1 Biomanufacturing Issues and Scalability
15.8.2 Policy, Regulation and Good Manufacturing Practice (GMP)
15.8.2.1 Regulatory Frameworks
15.8.2.2 Classification and Approval of Device
15.8.2.3 GMP and Quality Management
15.8.2.4 Data Integrity and Digital Regulatory Compliance
15.8.2.5 Future Directions and Evolution
15.8.3 Quality Control and Standardization
15.8.3.1 Standardization Efforts
15.9 Prospects and Research Areas
15.9.1 Future Direction of Bio-Ink Designs
15.9.1.1 Problems and Future
15.9.2 Advanced Bioprinting Technologies Integration
15.9.3 Personalized Therapeutics Sustainable Therapeutics
15.9.3.1 Personalized Therapeutics
15.9.3.2 Sustainable Therapeutics
15.9.3.3 Future Directions and Enabling Technologies
15.10 Conclusions
References
16. Bioprocess Optimization Using Artificial Intelligence and Machine Learning
K.S.N.V. Prasad, Bijoy Kumar Purohit, Bhaskar Bethi and A.V. Raghavendra Rao
16.1 Introduction to Bioprocess Optimization
16.1.1 Definition and Importance of Bioprocess Optimization
16.1.2 Limitations of Traditional Bioprocess Methods
16.1.3 Emergence of AI and ML in Biomanufacturing
16.2 Fundamentals of AI and ML in Bioprocessing
16.2.1 Overview of Artificial Intelligence and Machine Learning
16.2.2 Common AI/ML Algorithms in Bioprocess Applications
16.2.3 Data Requirements and Challenges in Bioprocess Modeling
16.3 AI/ML Integration in Upstream Bioprocessing
16.3.1 Cell Culture Optimization
16.3.2 Media Formulation and Feeding Strategies
16.3.3 Neural Networks and Design of Experiments (DOE)
16.4 AI/ML in Fermentation Process Control
16.4.1 Predictive Modeling of Fermentation Parameters
16.4.2 Dynamic Management of pH, Temperature and Oxygen Levels
16.4.3 Actual-Time Fermentation Monitoring Real-World Case Studies Using ML
16.5 AI/ML in Downstream Processing and Purification
16.5.1 Chromatography and Filtration Optimization
16.5.2 Predicting Product Purity and Yield
16.5.3 Adaptive Process Strategies for Complex Separations
16.6 Common Machine Learning Algorithms in Bioprocess Applications
16.6.1 Artificial Neural Networks (ANN)
16.6.2 Support Vector Machines (SVM)
16.6.3 Random Forests and Decision Trees
16.6.4 Deep Learning and Reinforcement Learning Models
16.7 Data Acquisition and Preprocessing in Biomanufacturing
16.7.1 Sources of Bioprocess Data (Sensors, SCADA, PAT)
16.7.2 Data Cleaning, Normalization, and Dimensionality Reduction
16.7.3 Feature Engineering and Time-Series Considerations
16.8 AI-Driven Process Modeling and Digital Twins
16.8.1 Development of Soft Sensors and Hybrid Models
16.8.2 How Digital Twins Can Be Used in Simulation and Process Optimization
16.8.3 Integration with Process Analytical Technologies (PAT)
16.9 Conclusion
References
17. Biomanufacturing of RNA Based Therapeutics and Vaccines: Advances, Issues and Prospects
Rompicherla Srividya, Navapet Vikas Reddy, Tirumala Shreya, Komere Vasu, Appala Naidu Uttaravalli, Manjakuppam Malika and A.V. Raghavendra Rao
17.1 Introduction to RNA-Based Therapeutics and Vaccines
17.1.1 General RNA Modalities: Modalities: mRNA, SiRNA, and Others
17.1.2 The Evolution and the Impact of the COVID-19 Pandemic Historically
17.1.3 Importance of Biomanufacturing in RNA Production
17.2 Upstream Processes in RNA Biomanufacturing
17.2.1 In Vitro Transcription (IVT) Techniques
17.2.2 Capping and Polyadenylation Strategies
17.2.3 Optimization of Template Design and Enzymes
17.2.4 Challenges in Upstream Scale-Up
17.3 Downstream Processes for RNA Purification and Formulation
17.3.1 RNA Purification Techniques: Chromatography and Filtration
17.3.2 Lipid Nanoparticle (LNP) Encapsulation Methods
17.3.3 Formulation for Stability and Delivery
17.3.4 Quality Control and Analytics in Downstream
17.4 Technological Innovations in RNA Biomanufacturing
17.4.1 Microfluidics for Precise Synthesis and Encapsulation
17.4.2 Single-Use Bioreactors and Modular Platforms
17.4.3 Real-Time Analytical Tools and PAT Integration
17.4.4 Automation and Digitalization in Processes
17.5 Scalability, GMP Compliance, and Regulatory Considerations
17.5.1 Strategies for Process Scale-Up and Tech Transfer
17.5.2 GMP Requirements for RNA Manufacturing
17.5.3 Regulatory Pathways and Approval Challenges
17.5.4 Cost-Effectiveness and Economic Modeling
17.6 Case Studies from mRNA Vaccine Production
17.6.1 COVID-19 mRNA Vaccines: Pfizer-BioNTech and Moderna
17.6.2 Scale-Up Campaigns and Global Distribution
17.6.3 Innovations in Rapid Manufacturing Response
17.6.4 Lessons from Production Bottlenecks
17.7 Challenges in RNA Biomanufacturing
17.7.1 Technical Challenges: Stability and Degradation
17.7.2 Supply Chain and Cold-Chain Logistics Issues
17.7.3 Immunogenicity and Safety Concerns
17.7.4 Economic and Accessibility Barriers
17.8 Future Prospects and Strategic Pathways
17.8.1 Thermostable Formulations and Novel Delivery Systems
17.8.2 Decentralized Manufacturing Hubs
17.8.3 Personalized and Next-Generation RNA Therapeutics
17.9 Conclusion
Abbreviations
References
Part 5: Bioprocessing and Sustainable Production
18. Rapid Biomanufacturing Strategies for Emerging Infectious Diseases: A New Era in Global Health Response
K.S.N.V. Prasad, Bhaskar Bethi, Bhanu Radhika, Manjakuppam Malika, B. Karuna, Vijaya Kumar Talari, Appala Naidu Uttaravalli and A.V. Raghavendra Rao
18.1 Introduction to Rapid Biomanufacturing in Global Health
18.1.1 Definition and Importance of Rapid Biomanufacturing
18.1.2 Biomanufacturing Evolution in Infectious Disease
18.1.3 Introduction to Emerging Infectious Diseases or Worldwide Problems
18.2 Historical Lessons from Recent Pandemics
18.2.1 Case Study: COVID-19 Pandemic Response
18.2.2 Insights from Ebola, Zika, and SARS Outbreaks
18.2.3 Key Failures in Traditional Biomanufacturing Approaches
18.2.4 Catalysts for Innovation in Rapid Manufacturing Cycles
18.3 Enabling Technologies for Agile Biomanufacturing
18.3.1 Plug-and-Play Modular Facilities
18.3.2 Cell-Free Expression Systems
18.3.3 Synthetic Biology Approaches
18.3.4 Comparative Analysis of Enabling Technologies
18.4 Platform Technologies for Biologics Development
18.4.1 mRNA Vaccine Platforms: Mechanisms and Advantages
18.4.2 Viral Vector Systems: Design and Applications
18.4.3 Monoclonal Antibodies and Antiviral Proteins
18.4.4 Flexibility and Speed in Platform Adaptation
18.5 Advanced Digital Tools and Process Control
18.5.1 Real-Time Process Control Systems
18.5.2 AI-Driven Modeling for Predictive Analytics
18.5.3 Digital Twins in Biomanufacturing Simulation
18.5.4 Data Integration and Cybersecurity Considerations
18.6 Decentralized and Just-in-Time (JIT) Manufacturing Strategies
18.6.1 Principles of Decentralized Production Units
18.6.2 JIT Biomanufacturing: Concepts and Implementation
18.6.3 Case Studies in Decentralized Vaccine Production
18.6.4 Challenges and Solutions in Scaling Decentralized Systems
18.7 Regulatory, Policy, and Supply Chain Frameworks
18.7.1 Regulatory Fast-Tracking Mechanisms
18.7.2 Global Supply Chain Coordination and Resilience
18.7.3 Policy Frameworks for Pandemic Preparedness
18.7.4 Ethical and Equity Considerations in Biomanufacturing
18.8 Future Directions and Roadmap for Resilient Infrastructures
18.8.1 Emerging Trends in Biomanufacturing Innovation
18.8.2 Building Resilient Global Health Infrastructures
18.8.3 Potential Roadblocks and Mitigation Strategies
18.8.4 Summing Up: On the Way to a New Age of Epidemic Response
18.9 Conclusion
18.9.1 Summary of Key Insights
18.9.2 Future Directions
18.9.3 Implications for Industry
Abbreviations
References
19. In-Line Monitoring and Advanced Control Strategies in Downstream Bioprocessing of Biologics
V. Sravani Sameera, Kamandla Manasa, K.S.N.V. Prasad, Bhanu Radhika, Karanam Hemanth Kumar, Appala Naidu Uttaravalli and A.V. Raghavendra Rao
19.1 Introduction to Downstream Bioprocessing of Biologics
19.1.1 Overview of Downstream Processing Stages
19.1.2 The Value of Quality and Efficiency in the Manufacturing of Biologics
19.1.3 Evolution of In-Line Monitoring and Advanced Controls
19.2 Principles of In-Line Monitoring in Downstream Processes
19.2.1 Critical Quality Attributes (CQAs) in Biologics Purification
19.2.2 Real-Time Data Acquisition and Sensor Technologies
19.2.3 Integration with Quality by Design (QbD) Frameworks
19.2.4 Challenges in Monitoring Complex Bioprocesses
19.3 Process Analytical Technology (PAT) Tools and Sensors
19.3.1 Spectroscopy-Based Sensors: NIR, Raman, and UV-Vis
19.3.2 Soft-Sensor Models for Predictive Monitoring
19.3.3 Applications in Filtration, Chromatography, and Formulation
19.3.4 Calibration and Validation of PAT Tools
19.4 Advanced Control Strategies in Bioprocessing
19.4.1 Model Predictive Control (MPC) Fundamentals
19.4.2 Feedback and Feedforward Control Mechanisms
19.4.3 Adaptive and Hybrid Control Algorithms
19.4.4 Real-Time Optimization of Process Parameters
19.5 Implementation of In-Line Monitoring and Controls
19.5.1 System Architecture for Real-Time Monitoring
19.5.2 Data Integration and Analytics Platforms
19.5.3 Case Studies in Industrial Scale-Up
19.5.4 Regulatory Compliance and GMP Considerations
19.6 Case Studies and Industry Applications
19.6.1 Enhanced Yield in Monoclonal Antibody Purification
19.6.2 Reduced Batch Failures in Viral Vector Processing
19.6.3 Improved Formulation Stability for Vaccines
19.6.4 Lessons Learned from Biopharmaceutical Implementations
19.7 Challenges and Solutions in Adoption
19.7.1 Sensor Calibration and Maintenance Challenges
19.7.2 Data Integration and Cybersecurity Risks
19.7.3 Process Validation and Scalability Issues
19.7.4 Strategies for Overcoming Implementation Barriers
19.8 Future Directions in Intelligent Biomanufacturing
19.8.1 Integration of Machine Learning and AI
19.8.2 Role of Digital Twins in Process Simulation
19.8.3 Sustainable and Green Bioprocessing Innovations
19.9 Conclusion
19.9.1 Summary of Key Insights
19.9.2 Future Directions
19.9.3 Implications for Industry
Abbreviations
References
20. Design of Experiments for Biopharmaceutical Process Optimization
Vijaya Kumar Talari, Baburao Gaddala, Bijoy Kumar Purohit, Stutee Bhoi, A. V. Raghavendra Rao, K.S.N.V. Prasad, Gowrishetty Srinivas and T. Srinivas
20.1 Introduction
20.1.1 Overview of DoE in Biopharma
20.1.2 Importance of Process Optimization
20.1.3 Chapter Objectives
20.2 Fundamentals of Design of Experiments (DoE)
20.2.1 Basic Principles of Design of Experiments (DoE)
20.2.2 Statistical Foundations
20.2.3 Role in Risk Assessment
20.3 Quality by Design (QbD) Framework
20.3.1 Quality by Design (QbD) Principles
20.3.2 Integration QbD with DoE
20.3.3 Regulatory Perspectives
20.4 Key Design of Experiments (DoE) in Biopharma
20.4.1 Factorial and Fractional Factorial
20.4.2 Response Surface Methodology (RSM)
20.4.3 Definitive Screening Designs (DSDs)
20.5 Applications in Process Development Stages
20.5.1 Cell Culture and Fermentation
20.5.2 Purification Processes
20.5.3 Formulation and Scale-Up
20.6 Case Studies
20.6.1 Resolving Bottlenecks
20.6.2 Reducing Variability
20.6.3 Accelerating Technological Transfer
20.7 Challenges and Best Practices
20.7.1 Model Overfitting and Limitations
20.7.2 Data Interpretation Strategies
20.7.3 Effective Planning Guidelines
20.8 Conclusion
20.8.1 Summary of Key Insights
20.8.2 Future Directions
20.8.3 Implications for Industry
References
21. Zero Waste Biomanufacturing Systems: Concepts and Case Studies
Bhaskar Bethi, Vijaya Kumar Talari, Bhanu Radhika Gidla, Bijoy Kumar Purohit, A. V. Raghavendra Rao, Stutee Bhoi and K.S.N.V. Prasad
21.1 Introduction to Zero-Waste Biomanufacturing
21.1.1 Principles of Circular Economy
21.1.2 Scope of the Chapter
21.2 Core Concepts of Zero-Waste Biomanufacturing
21.2.1 Waste Minimization Strategies
21.2.2 Biorefinery Integration
21.2.3 Lifecycle Assessment (LCA)
21.2.4 Synthesis and Implications
21.3 Technological Approaches
21.3.1 Advanced Bioprocessing Techniques
21.3.2 Synthetic Biology for Waste Valorization
21.3.3 Renewable Feedstocks
21.4 Case Studies
21.4.1 Biofuel Production with Zero-Waste
21.4.1.1 Background and Context
21.4.1.2 Process Description
21.4.1.3 Case Example: Integrated Lignocellulosic Biorefinery
21.4.1.4 By-Product Management
21.4.1.5 Technological Innovations
21.4.1.6 Challenges and Solutions
21.4.2 Bioplastics and Waste Recycling
21.4.2.1 Introduction
21.4.2.2 Bioplastics: Types and Production Processes
21.4.2.3 Waste Recycling in Bioplastics Manufacturing
21.4.2.4 Industrial Example: NatureWorks and PLA Production
21.4.2.5 Industrial Example: Mango Materials and PHA Production
21.4.2.6 Challenges in Zero-Waste Bioplastics Manufacturing
21.4.3 Agricultural Waste Valorization
21.4.3.1 Anaerobic Digestion of Agricultural Waste for Biogas and Biofertilizers
21.4.3.2 Synthesis and Implications
21.5 Challenges and Opportunities
21.5.1 Technical and Economic Barriers
21.5.2 Regulatory Considerations
21.5.3 Scalability Issues
21.5.4 Opportunities for Advancement
21.6 Future Directions
21.6.1 Emerging Technologies
21.6.2 Industry 4.0 in Biomanufacturing
21.6.3 Conclusion
References
22. Green Chemistry in Upstream Bioprocessing
Vijaya Kumar Talari, Stutee Bhoi and Bijoy Kumar Purohit
22.1 Introduction to Green Chemistry in Upstream Bioprocessing
22.1.1 Principles of Green Chemistry and Their Relevance to Bioprocessing
22.1.2 Environmental Challenges in Traditional Upstream Processes
22.1.3 Objectives of Sustainable Bioprocessing
22.2 Sustainable Media Preparation
22.2.1 Development of Eco-Friendly Media Formulations
22.2.2 Use of Renewable and Biodegradable Feedstocks
22.2.3 Minimizing Auxiliary Chemicals in Media Design
22.3 Green Cell Culture Strategies
22.3.1 Solvent-Free and Benign Solvent Systems
22.3.2 Optimizing Cell Lines for Reduced Environmental Impact
22.3.3 Innovations in Serum-Free and Chemically Defined Media
22.4 Energy-Efficient Fermentation Processes
22.4.1 Design of Low-Energy Bioreactor Systems
22.4.2 Application of Atom Economy in Fermentation
22.4.3 Waste Heat Recovery and Energy Optimization Techniques
22.5 Metabolic Engineering for Sustainability
22.5.1 Engineering Pathways for Higher Yields and Lower By-Products
22.5.2 Reducing Hazardous Intermediates Through Synthetic Biology
22.5.3 Case Studies in Sustainable Metabolic Engineering
22.6 Process Intensification for Green Bioprocessing
22.6.1 High-Cell-Density Cultures for Resource Efficiency
22.6.2 Continuous Bioreactor Systems and Their Benefits
22.6.3 Integration of Process Analytical Technologies (PAT)
22.7 Case Studies in Green Upstream Bioprocessing
22.7.1 Academic Innovations in Sustainable Bioprocessing
22.7.2 Industrial Applications and Measurable Outcomes
22.7.3 Lessons Learned from Scalable Green Processes
22.8 Conclusion
22.8.1 Regulatory Considerations for Green Bioprocessing
22.8.2 Economic and Scalability Barriers
22.8.3 Emerging Trends and Technologies for Sustainable Biomanufacturing
22.8.4 Future Directions
References
23. Regulatory Compliance and Quality‑by-Design (QbD) in Biologic Manufacturing: Ensuring Robust and Scalable Bioproduction
Abishek Balasundaram, Bava Dhareni Pandia Rajan, Jenifer Appadurai, Venkateshan Narayanan and Thenmozhi Annadurai
23.1 Introduction
23.2 Regulatory Framework for Biologics
23.2.1 Regulatory Agencies
23.2.1.1 World Health Organization (WHO)
23.2.1.2 Pan American Health Organization (PAHO)
23.2.1.3 International Conference on Harmonization (ICH)
23.2.1.4 Food and Drug Administration (FDA)
23.2.1.5 Central Drugs Standard Control Organization (CDSCO)
23.2.2 Quality Control in Biologics
23.2.2.1 Guidelines and Regulation for Biologics in India
23.2.2.2 Approval Process in Biologics
23.2.2.3 Requirements for Biologics Approval
23.2.3 Challenges for Implementation of Regulatory Framework in Biologics
23.3 Quality-by-Design
23.3.1 Aims, Results and Characteristics of QbD
23.3.2 Principles of QbD
23.3.2.1 Quality Target Product Profile (QTPP)
23.3.2.2 Critical Quality Attributes (CQAs)
23.3.2.3 Risk Assessment
23.3.2.4 Critical Material Attributes & Process Parameter
23.3.2.5 Design Space
23.3.2.6 Control Strategy
23.3.2.7 Lifecycle Approach to Product Quality
23.3.3 QbD vs Conventional Quality System
23.3.4 Applications for QbD
23.4 QbD Implementation in Biologic Manufacturing
23.4.1 Establishing the Design Space Using Design-of-Experiment Techniques
23.4.1.1 QTPP
23.4.1.2 CQA
23.4.1.3 Risk Analysis
23.4.1.4 Design Space
23.4.1.5 Design of Experiment
23.4.1.6 Control Strategy
23.5 Challenges in the Implementation of QbD
23.6 Role of Digital Tools and Automation
23.6.1 Artificial Intelligence and Machine Learning
23.6.2 Digital Twin
23.6.3 Process Analytical Technology (PAT)
23.6.4 Internet of Things (IoT)
23.6.5 Robotics
23.6.6 Blockchain Technology
23.7 Future Direction
23.8 Conclusion
References
24. AI-Driven Predictive Maintenance for Biomanufacturing Equipment
Anup Ashok, Vijaya Kumar Talari, Bijoy Kumar Purohit, A. V. Raghavendra Rao, Stutee Bhoi and K.S.N.V. Prasad
24.1 Introduction to Predictive Maintenance in Biomanufacturing
24.2 Technical Foundations of AI-Driven Predictive Maintenance
24.3 Applications of AI in Bioprocessing Equipment
24.4 Case Studies: AI-Enabled Predictive Maintenance in Action
24.5 Challenges in Implementing AI-Driven Predictive Maintenance
24.6 Future Trends in AI-Driven Maintenance for Biomanufacturing
24.7 Practical Considerations for Biomanufacturing Leaders
24.8 Conclusion
References
Part 6: Quality, Regulation, and Risk Management
25. Risk Management and Safety Engineering in Large-Scale Biomanufacturing
A.V. Raghavendra Rao, Kolluru Manaswini, Thalluri Lavanya, Mulla Murali Ganesh, Srimukhi Mekala, Chitti Babu Nalluri and Sravani Sameera Vanjarana
25.1 Introduction
25.1.1 Scope of Risk and Safety Issues in Manufacturing of Biologics
25.1.2 Key Differences between Small-Scale and Large-Scale Bioprocessing
25.1.2.1 Purpose and Objectives
25.1.2.2 Process Control and Monitoring
25.1.2.3 Equipment and Infrastructure
25.1.2.4 Risk Management Approach
25.1.2.5 Cost and Resource Implications
25.1.2.6 Regulatory Environment
25.1.3 The Significance of Safety Engineering Integration in the Design of Process
25.1.3.1 Enhanced Compliance and Regulatory Approval
25.1.3.2 Improved Process Reliability and Uptime
25.1.3.3 Lower Operational Costs over the Product Lifecycle
25.1.3.4 Protection of Personnel and Corporate Reputation
25.1.3.5 Sustainability and Environmental Stewardship
25.2 Understanding Risk in Biomanufacturing
25.2.1 Types of Risks
25.2.1.1 Biological Risks
25.2.1.2 Chemical Risks
25.2.1.3 Physical Risks
25.2.1.4 Ergonomic Risks
25.2.1.5 Environmental Risks
25.2.2 Key Risk Sources
25.2.2.1 Live Organisms
25.2.2.2 Media Handling
25.2.2.3 Pressurized Systems
25.2.2.4 Aseptic Processes
25.2.3 Risk Assessment Methodologies: Qualitative and Quantitative
25.2.3.1 Qualitative Risk Assessment
25.2.3.2 Quantitative Risk Assessment
25.3 Safety Engineering Principles
25.3.1 Hierarchy of Hazard Control
25.3.2 Engineering Design for Safety
25.4 Occupational Safety Management
25.4.1 Worker Exposure Limits and Monitoring
25.4.2 PPE and Safety Practice in Cleanrooms and Wet Labs
25.4.3 Training Programs and Behavior-Based Safety
25.4.4 Incident Reporting and Root Cause Analysis
25.5 Environmental Safety and Emission Control
25.5.1 Liquid and Gaseous Waste Management
25.5.2 Bioburden and Nutrient Discharge Risks
25.5.3 Effluent Treatment and Regulatory Thresholds
25.5.4 Use of Green Engineering and Process Optimization
25.6 Regulatory Frameworks and Standards
25.6.1 Overview of Key Regulations
25.6.1.1 Occupational Safety and Health Administration (OSHA)
25.6.1.2 ISO 45001 (Occupational Health and Safety Management Systems)
25.6.1.3 NFPA (National Fire Protection Association)
25.6.1.4 Environmental Protection Agency (EPA)
25.6.1.5 European Medicines Agency (EMA) and US Food and Drug Administration (FDA)
25.6.2 Integration of EHS into Quality Management Systems (QMS)
25.6.2.1 Benefits of Integration
25.7 Digital Safety Tools and Automation
25.7.1 The Potential Role of AI, IoT and Predictive Analytics in Real-Time Risk Monitoring
25.7.1.1 Artificial Intelligence (AI)
25.7.1.2 Internet of Things (IoT)
25.7.1.3 Predictive Analytics
25.7.2 Digital Twins and Process Simulations for Hazard Forecasting
25.7.2.1 Digital Twins
25.7.2.2 Hazard Forecasting
25.8 Future Directions
25.9 Conclusion
References
26. Sustainable Downstream Processing: Green Alternatives for Purification of Biologics
A.V. Raghavendra Rao, V. Sravani Sameera, Ch. Vishnu Vardhan, Mohith Patil, Panduga Rahul and Rompicherla Srividya
26.1 Introduction to Sustainable Downstream Processing
26.1.1 Environmental Impact of Traditional DSP Methods
26.1.2 Strategic Imperatives for Sustainable Downstream Processing
26.2 Green Chemistry and Engineering Principles in Downstream Processing
26.2.1 Application of Green Chemistry Principles in DSP
26.2.2 Process Intensification, Waste Minimization, and Solvent Reduction
26.2.3 Metrics for Evaluating Sustainability in Purification
26.3 Sustainable Cell Harvesting and Clarification Techniques
26.3.1 Re-Evaluating Traditional Centrifugation
26.3.2 Alternatives to Centrifugation: Acoustic Wave Separation and Depth Filtration
26.3.2.1 Acoustic Wave Separation (AWS)
26.3.2.2 Depth Filtration
26.3.3 Single-Use and Closed Systems: Reducing Waste and Contamination
26.3.4 Energy-Efficient and Low-Shear Methods
26.3.5 Industrial Examples and Integration with Continuous Bioprocessing
26.4 Green Alternatives in Chromatography and Separation
26.4.1 Membrane Chromatography: High Throughput with Low Impact
26.4.2 Monolithic Chromatography: Continuous Pores, Continuous Sustainability
26.4.3 Recyclable and Bio-Based Resins: Optimizing Its Use and Minimizing Waste
26.4.4 Aqueous-Based Mobile Phases and Green Solvents
26.4.5 Low Impact Magnetic and Affinity Based Separation
26.5 Integration and Process Intensification Approaches
26.5.1 Continuous and Integrated DSP Platforms
26.5.2 Inline Buffer Preparation and Real-Time Monitoring
26.5.3 Coupling Upstream and Downstream Operations for Efficiency
26.5.4 Industrial Adoption and Case Studies
26.6 Life Cycle Assessment (LCA) and Environmental Impact Analysis
26.6.1 Downstream Processing LCA Principles and Scopes
26.6.2 Comparative LCA: Conventional vs. Sustainable DSP Strategies
26.6.3 Carbon Footprint, Water Usage, and Waste Generation
26.6.4 Sustainability Indicators for DSP Design
26.6.5 Tools and Software for LCA in Bioprocessing
26.7 Challenges, Industrial Applications, and Future Outlook
26.7.1 Obstacles and Scalability Barriers and Regulations Adoptions
26.7.2 Industrial Case Studies and Success Stories
26.7.3 Future Perspectives; Digitalization, Synthetic Biology and Circular Bioprocessing
26.8 Conclusion
References
Part 7: Future Directions and Advances
27. Next-Gen Nanocarriers for Transdermal Transport of Therapeutic Biologics
Gurugubelli Sowjanya, Varri Ambica Taruni and Kommula L. N. S. S. Dharani Devi
27.1 Introduction
27.1.1 Overview of Transdermal Drug Delivery Systems (TDDS)
27.1.2 Importance of Biological Therapeutics
27.1.3 Limitations of Classic Delivery Methods
27.2 The Skin Barrier and Challenges in Transdermal Delivery
27.2.1 Anatomy and Physiology of the Skin
27.2.2 Physicochemical Barriers to Transdermal Delivery
27.2.3 Immunological and Enzymatic Barriers
27.2.4 Mechanical and Structural Resistance
27.2.5 Methods to Overcome the Epidermal Barrier
27.2.6 The Need for Next-Generation Nanocarriers
27.3 Overview of Nanocarrier Systems
27.3.1 Introduction to Nanocarriers in Transdermal Delivery
27.3.2 Classification of Nanocarrier Systems
27.3.2.1 Lipid-Based Nanocarriers
27.3.2.2 Polymeric Nanoparticles
27.3.2.3 Dendrimers
27.3.2.4 Nano Emulsions and Microemulsions
27.3.2.5 Metallic and Inorganic Nanoparticles
27.3.3 Mechanisms of Nanocarrier Penetration through the Skin
27.3.4 Advantages of Nanocarriers in Biological Drug Delivery
27.3.5 Examples of Nanocarrier-Based Transdermal Biological Systems
27.3.6 Safety and Regulatory Considerations
27.4 Keen: Stimuli-Responsive Nano Carriers
27.4.1 pH-Responsive Nanocarriers
27.4.2 Thermo-Responsive Nanocarriers
27.4.3 Enzyme-Sensitive Systems
27.4.4 Magnetic and Light Triggered Responsive Nanocarriers
27.5 Sorts of Nanocarriers for Transdermal Delivery
27.5.1 Liposomes and Transferosomes
27.5.1.1 Liposomes
27.5.1.2 Transferosomes
27.5.2 Ethosomes and Niosomes
27.5.2.1 Ethosomes
27.5.2.2 Niosomes
27.5.3 Solid Lipid Nanoparticles and Nanostructured Lipid Carriers (NLCs)
27.5.3.1 Solid Lipid Nanoparticles
27.5.3.2 Nanostructured Lipid Carriers (NLCs)
27.5.4 Polymeric Nanoparticles
27.5.5 Dendrimers
27.6 Design of Nanocarriers for Biological Therapeutics
27.6.1 Nucleic Acids (DNA, SiRNA, mRNA)
27.6.1.1 DNA Nanostructures
27.6.1.2 SiRNA Nanostructures
27.6.1.3 MiRNAs Nanostructures
27.6.2 Peptides and Proteins
27.6.3 Monoclonal Antibodies and Vaccines
27.7 Surface Building and Functionalization
27.7.1 PEGylation and Stealth Strategies
27.7.2 Cell-Penetrating Peptides (CPPs)
27.8 Crossover and Multi-Layered Nanocarriers
27.8.1 Core-Shell Nanostructures
27.8.2 Lipid-Polymer Hybrids
27.8.3 Nanogels and Hydrogel
27.8.4 Self-Assembled Nanostructures
27.9 Components of Nanocarriers Infiltration through Skin
27.9.1 Passive Dissemination vs. Dynamic Transport
27.9.1.1 Passive Methods
27.9.1.2 Active Methods
27.9.2 Endocytosis and Transcytosis
27.9.2.1 Endocytosis
27.9.2.2 Transcytosis
27.9.3 Disruption of Tight Intersections and Lipid Bilayers
27.10 Preclinical and Clinical Evaluation
27.10.1 In Vitro Models (Franz Cells, Manufactured Skin)
27.10.2 Extracorporeal Homo Sapiens Skin Models
27.10.3 Ex Vivo Human Skin: Utilize in Bioequivalence Studies
27.10.4 Ex Vivo Creature Skin Models
27.10.5 Artificial and Remade Skin Models
27.10.6 Clinical Studies for Transdermal Nanoparticle Delivery System
27.11 Administrative, Fabricating, and Adaptability Aspects
27.11.1 Regulatory Systems (FDA, EMA)
27.11.2 Scale-Up Challenges and Solutions
27.12 Challenges and Future Directions
27.13 Conclusion
References
28. Recent Advances in Biocatalysis and Metabolic Engineering for Biomanufacturing
Saivenkatesh Korlam, Sankara Rao Miditana and Satheesh Ampolu
28.1 Introduction
28.2 Advances in Biocatalysis
28.2.1 Enzyme Based Engineering
28.2.2 Enzyme Immobilization
28.2.3 Cascade Reactions
28.3 Advances in Metabolic Engineering
28.3.1 Pathway Optimization
28.3.2 Microbial Host Design
28.3.3 Systems Biology Integration
28.4 Applications in Biomanufacturing
28.4.1 Pharmaceuticals
28.4.2 Biofuels
28.4.3 Sustainable Chemicals
28.5 Challenges and Limitations
28.6 Future Perspectives
28.7 Conclusion
References
Index

Back to Top



Description
Author/Editor Details
Table of Contents
Bookmark this page